Cost-effectiveness of pioglitazone versus acarbose, metformin, and sulphonylureas in the United Kingdom

Authors: Palmer A.J.; Weiss C.; Roze S.; Bumann E.; Foerdoes L.; Brandt A.; Spinas G.A.

Source: Diabetes Research and Clinical Practice, Volume 50, Supplement 1, September 2000 , pp. 193-193(1)

Publisher: Elsevier

Buy & download fulltext article:

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Language: English

Document Type: Abstract

DOI: http://dx.doi.org/10.1016/S0168-8227(00)82116-6

Publication date: 2000-09-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page